Trupanion (TRUP) to Release Earnings on Thursday

Trupanion (NASDAQ:TRUP) is scheduled to release its earnings data after the market closes on Thursday, November 8th. Analysts expect Trupanion to post earnings of ($0.01) per share for the quarter.

TRUP opened at $25.69 on Tuesday. Trupanion has a 52 week low of $22.55 and a 52 week high of $46.70. The firm has a market cap of $827.41 million, a PE ratio of -367.00 and a beta of 1.08. The company has a quick ratio of 3.04, a current ratio of 3.04 and a debt-to-equity ratio of 0.16.

Several research firms have recently commented on TRUP. Stifel Nicolaus raised their price target on Trupanion from $34.00 to $40.00 and gave the stock a “buy” rating in a research report on Tuesday, July 10th. Zacks Investment Research upgraded Trupanion from a “sell” rating to a “hold” rating and set a $42.00 price target for the company in a research report on Tuesday, August 7th. BidaskClub lowered Trupanion from a “hold” rating to a “sell” rating in a research report on Tuesday, October 9th. Cowen raised their price target on Trupanion from $41.00 to $47.00 and gave the stock a “positive” rating in a research report on Friday, August 3rd. Finally, Royal Bank of Canada raised their price target on Trupanion to $44.00 and gave the stock an “outperform” rating in a research report on Friday, August 3rd. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $45.22.

In related news, CEO Darryl Rawlings sold 4,000 shares of Trupanion stock in a transaction on Wednesday, August 8th. The stock was sold at an average price of $38.18, for a total value of $152,720.00. Following the completion of the transaction, the chief executive officer now directly owns 1,293,989 shares in the company, valued at $49,404,500.02. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Murray B. Low sold 3,000 shares of Trupanion stock in a transaction on Friday, August 10th. The shares were sold at an average price of $38.12, for a total value of $114,360.00. Following the completion of the transaction, the director now owns 189,782 shares of the company’s stock, valued at $7,234,489.84. The disclosure for this sale can be found here. Over the last quarter, insiders sold 27,450 shares of company stock valued at $935,886. 20.70% of the stock is currently owned by company insiders.

A hedge fund recently raised its stake in Trupanion stock. Bank of New York Mellon Corp lifted its stake in Trupanion Inc (NASDAQ:TRUP) by 3.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 84,145 shares of the financial services provider’s stock after purchasing an additional 2,967 shares during the period. Bank of New York Mellon Corp owned about 0.26% of Trupanion worth $3,248,000 at the end of the most recent quarter. 93.62% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This piece was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/11/06/trupanion-trup-to-release-earnings-on-thursday.html.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Read More: What are the most popular ETFs

Earnings History for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply